DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00252863 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1600

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Symbicort, used twice daily (b.i.d) and as needed (prn)
DRUG: Budesonide Turbuhaler 200 µg
DRUG: Fluticasone Discus 250 µg
DRUG: Formoterol Turbuhaler 4.5 µg
DRUG: Terbutaline Turbuhaler 0.5 mg
DRUG: Salbutamol pressurized metered dose inhaler (pMDI) 100 µg
DRUG: Salmeterol Discus 50 µg
DRUG: Budesonide/Formoterol Turbuhaler 160/4.5 µg
DRUG: Fluticasone/Salmeterol Discus 250/50 µg
DRUG: Fluticasone/Salmeterol Discus 500/50 µg
DRUG: Theophylline 200 mg
DRUG: Theophylline 300 mg
DRUG: Singulair 10 mg

Sponsor

AstraZeneca